Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rite Aid Joins Fragmented Electronic Effort Against “Smurfing”

This article was originally published in The Tan Sheet

Executive Summary

Some drugstore chains are tracking sales of methamphetamine precursors with their own electronic systems, but Sen. Chuck Grassley says a national approach may be needed to effectively prevent consumers from evading limits on retail purchases of the products

You may also be interested in...



Tennessee Emerges As PSE Battleground With Rx, NPLEx Proposals

The conflict between electronic tracking of pseudoephedrine purchases and shifting the drug ingredient to prescription-only status is elevated in Tennessee as lawmakers offer bills for both anti-methamphetamine strategies.

Tennessee Emerges As PSE Battleground With Rx, NPLEx Proposals

The conflict between electronic tracking of pseudoephedrine purchases and shifting the drug ingredient to prescription-only status is elevated in Tennessee as lawmakers offer bills for both anti-methamphetamine strategies.

Tennessee Emerges As PSE Battleground With Rx, NPLEx Proposals

The conflict between electronic tracking of pseudoephedrine purchases and shifting the drug ingredient to prescription-only status is elevated in Tennessee as lawmakers offer bills for both anti-methamphetamine strategies.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102563

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel